Recessive congenital methemoglobinemia: a systematic review of reported cases
Open Access
- 4 February 2026
- journal article
- review article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 21 (1)
Abstract
Background: Recessive congenital methemoglobinemia (RCM) is a rare autosomal recessive disorder characterized by a deficiency of NADH-cytochrome b5 reductase. Under normal conditions, cytochrome b5 reductase and NADH reductase maintain methemoglobin in the physiological range by keeping heme iron in the Fe 2 + state. RCM presents in two clinical forms. Type I presents with isolated cyanosis, while type II presents also with severe neurocognitive manifestations. Genetic analysis of the CYB5R3 gene is often used for diagnosis. Treatment with methylene blue, ascorbic acid, or riboflavin can reduce cyanosis, but does not affect neurological outcomes. Main body: We conducted a systematic review of RCM, identifying all previously reported cases, including one from our center. In addition, we conducted a meta-analysis of individual participant data and provided a comprehensive review of clinical manifestations, genotype-phenotype correlations and treatment options, as well as proposing a diagnostic flow chart. Conclusion: In the case of RCM, diagnosis is primarily achieved through genetic analysis based on direct sequencing. The described pathogenic variants are specific to either type I or type II RCM when considered in combination with their allelic variants in compound heterozygous cases. Well known variants such as c.757G>A is associated with type I in both homo- and heterozygous state. Whereas c.226G> is associated with type I in compound heterozygous state with c.173G>A or c.827C>T and type 2 in homozygous state. Similar results are observed for multiple other variants. Ascorbic acid is the most commonly used treatment. Clinical trial number: Not applicable.Keywords
This publication has 86 references indexed in Scilit:
- Recommendations for diagnosis and treatment of methemoglobinemiaAmerican Journal of Hematology, 2021
- A rare cause of cyanosis: Congenital methemoglobinemiaClinical Case Reports, 2021
- Mutation update: Variants of the CYB5R3 gene in recessive congenital methemoglobinemiaHuman Mutation, 2020
- A new mutation of congenital methemoglobinemia exacerbated after methylene blue treatmentAcute Medicine & Surgery, 2018
- Congenital methemoglobinemia type II in a 5‐year‐old boyClinical Case Reports, 2017
- Severe mental retardation and recessive congenital methemoglobinemia in three Indian patients: Compound heterozygous for NADH‐cytochrome b5 reductase gene mutationsAmerican Journal of Hematology, 2011
- Molecular basis of recessive congenital methemoglobinemia, types I and II: Exon skipping and three novel missense mutations in the NADH-cytochrome b5 reductase (diaphorase 1) geneHuman Mutation, 2001
- A case of methemoglobinemia type II due to NADH-cytochrome b5 reductase deficiency: Determination of the molecular basisHuman Mutation, 2000
- A splicing mutation in the cytochrome b5 gene from a patient with congenital methemoglobinemia and pseudohermaphrodismHuman Genetics, 1994
- Lipids of myelin, white matter and gray matter in a case of generalized deficiency of cytochrome b5 reductase in congenital methemoglobinemia with mental retardationLipids, 1980